Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 118

Medication adherence in heart failure patients with reduced ejection fraction and related factors at the Vietnam National Heart Institute, Bach Mai Hospital

Tran Tuan Viet: Hanoi Medical University;
Published: November 28, 2025
Views: 104

Abstract

Background: Medication adherence is crucial to optimize outcomes in heart failure with reduced ejection fraction (HFrEF), yet determinants of adherence in Vietnamese patients remain under-described.
Objectives: To (1) assess medication adherence in hospitalized HFrEF patients and (2) identify factors associated with adherence at the Viet Nam National Heart Institute.

Methods: Cross-sectional study of adults (≥18 years) with HFrEF (EF ≤40%) admitted from July–October 2024. Sociodemographic and clinical data were collected via face-to-face interview and chart review. Adherence was measured using the 11-item General Medication Adherence Scale (GMAS; total score 0–33). Patients were classified as adherent (≥ 27) or non-adherent (≤ 26). Descriptive statistics, chi-square tests, and multivariable logistic regression were applied (p<0.05).
Results:
 Of 107 patients (mean age 66.61±12.08 years; 56.1% male), hypertension (50.5%) and diabetes (38.3%) were the most common comorbidities; mean EF was 36.14±3.08%; NYHA class II and III accounted for 42.1% and 57.9%, respectively. The mean GMAS total score was 28.21±3.63. By GMAS domains, mean scores were PBNA 12.50±2.21, ADPB 10.48±1.55, and CRNA 5.23±0.86. Using the study classification, 74.8% were adherent and 25.2% non-adherent.

In bivariable analysis, renal failure (p=0.021) and shorter disease duration (p=0.035) were associated with non-adherence. In multivariable models, female sex (aOR 5.35; 95%CI 1.27–22.48; p=0.02) and education ≥ secondary (aOR 12.66–14.80; p<0.01) independently predicted higher adherence; age, economic source, comorbidities, and NYHA class were not significant. Behavior-related non-adherence (PBNA) was the most frequent domain-specific barrier (18.7%), followed by cost-related (16.8%) and pill-burden/comorbidity (10.3%).

Conclusions: Nearly three-quarters of hospitalized HFrEF patients were adherent to medications. Higher education and female sex were independent correlates of better adherence, whereas behavioral barriers predominated among non-adherent patients. Patient-centered education and practical adherence supports (e.g., reminders, counseling) should be prioritized to improve outcomes.

References

1.
Lam WY, Fresco P. Medication Adherence Measures: An Overview. BioMed Res Int. 2015;2015:1-12. doi:10.1155/2015/217047
2.
Naqvi AA, Hassali MA, Rizvi M, et al. Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan. Front Pharmacol. 2018;9:1124. doi:10.3389/fphar.2018.01124
3.
Nguyen NK, Diep HG, Ly HHV, et al. Medication Adherence and Belief about Medication among Vietnamese Patients with Chronic Cardiovascular Diseases within the Context of Implementing Measures to Prevent COVID-19. J Cardiovasc Dev Dis. 2022;9(7):202. doi:10.3390/jcdd9070202
4.
Kukulska A, Garwacka-Czachor E. Assessment of adherence to treatment recommendations among patients with heart failure: a cross-sectional study. BMC Cardiovasc Disord. 2024;24(1):337. doi:10.1186/s12872-024-04001-y
5.
Tsige AW, Kotiso TA, Ayenew KD, Ayele SG. Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital. Pharmacol Res Perspect. 2024;12(3):e1199. doi:10.1002/prp2.1199
6.
Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and Drug Adherence in the Elderly. Front Cardiovasc Med. 2020;7:49. doi:10.3389/fcvm.2020.00049
7.
Chen LC, Chen TC, Huang YB, Chang CS. Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients. Int J Clin Pharm. 2014;36(1):120-127. doi:10.1007/s11096-013-9867-8
8.
Goldsmith LJ, Kolhatkar A, Popowich D, Holbrook AM, Morgan SG, Law MR. Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application. Soc Sci Med. 2017;194:51-59. doi:10.1016/j.socscimed.2017.10.007

Files

Article Views104
Document Views1
Downloads0
Section NGHIÊN CỨU LÂM SÀNG
Issue Số 118
Pages 126-132